Superconducting synchrocyclotron and hadron treatment facility for simultaneously accelerating multiple ion species
By adopting a combination of multiple ion sources and modulation devices in hadron therapy facilities, the limitations of existing facilities in efficiency and accuracy are overcome, and efficient and accurate dose deposition and moving target irradiation are achieved.
Patent Information
- Application Number
- CN202510273424.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-03-12
- Filing Date
- 2025-03-10
- Publication Date
- 2025-09-12
AI Technical Summary
Existing hadron therapy facilities have limitations in efficiency and precision, especially in achieving accurate dose deposition when the target volume is close to organs at risk.
At least two ion sources are used to generate treatment and imaging beams respectively. Combined with an axial injection pipeline, a high-frequency buncher, a high-frequency modulation device, a rotating path modulator and a chopper, efficient acceleration and precise path modulation of multiple ions are achieved through a synchrocyclotron accelerator, and the Bragg peak characteristics are used to improve the dose deposition accuracy.
It improves the lateral and axial ballistic accuracy of the treatment beam, increases biological efficiency, achieves precise irradiation in a short time, supports "flash therapy" technology, and can accurately irradiate moving targets.
Smart Images

Figure CN120640511A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to particle accelerators and, more specifically, to synchrocyclotrons. The latter offer an interesting solution for accelerating protons and other light ions to high energies for medical radiotherapy applications, known as hadron therapy, which exploits the Bragg peak characteristic of these particles as they decelerate in tissue, increasing the dose delivered at the end of their path. Background Art
[0002] The compactness of this accelerator reduces physical size and investment costs, making its installation in a hospital environment practical.
[0003] The following publications describe examples of superconducting synchrocyclotrons that allow for the acceleration of proton beams for high-energy proton therapy:
[0004] - Gordon M., Wu X., "Extraction studies for a 250 MeV Superconducting Synchrocyclotron." Proceedings of the Acceleration Conference (USA, 1987) pp. 1255-1257,
[0005] -Y. Jongen, P. Mandrillon, M. Abs, W. Kleeven, S. Quets, P. Verbruggen, “Development of the new IBA S2C2,” 2012 European Cyclotron Progress Conference, PSI, Switzerland
[0006] - W. Kleeven et al., IBA, Louvain-la-Neuve (B), M. Conjat et al., AIMA Development, Nice (F), “The IBA Superconducting Synchrocyclotron project S2C2,” Proceedings of the Cyclotron Society 2013, Vancouver, Canada.
[0007] Hadron therapy systems must meet requirements for efficiency and precision, as it is important to know exactly where the dose is deposited, especially when the target volume is close to organs at risk.
[0008] In this regard, existing facilities could be improved.
[0009] Invention Introduction
[0010] Therefore, there is a need to further improve the performance of hadron therapy facilities by overcoming the limitations of high-energy proton therapy.
[0011] There is also interest in improving the superconducting synchrocyclotron used in such facilities. Summary of the Invention
[0012] The present invention aims to meet all or part of these needs and does so by proposing a superconducting synchrocyclotron comprising:
[0013] at least two ion sources for respectively generating a so-called "therapy" beam of at least a first type of ions and a so-called "imaging" beam consisting of deuterons,
[0014] - an axial injection line comprising at least one high-frequency buncher ("buncher") for bunching the ions delivered by the ion source before injecting them into the intermediate acceleration plane of the synchrocyclotron,
[0015] - a high-frequency modulation device for generating a cyclic frequency law F(t) within the synchrocyclotron, allowing simultaneous acceleration of the ions of the treatment beam and the imaging beam,
[0016] a rotating path modulator placed in the path of the therapeutic beam and imaged after ion acceleration, comprising at least one solid area and at least one empty area positioned alternately during the rotation of the modulator in the path of said beam, the path modulator being capable of modulating the path of the therapeutic ions in the target volume,
[0017] - Two choppers ("choppers" in English) upstream of the intermediate acceleration plane, for modulating the treatment beam and the imaging beam synchronously with the rotation of the path modulator, so that ions of the treatment beam only pass through the at least one solid region, and ions of the imaging beam only pass through the at least one empty region.
[0018] This particle accelerator, in which the frequency of the accelerator electric field varies with time, is capable of accelerating, in addition to deuterons, ions with a charge-Z-mass-A ratio close to that of deuterons, such as α( 4 He 2+ ), 12 C 6+ (C6+) or 7 Li 3+ (Li 3+) ions. Therefore, the accelerator according to the present invention can accelerate 7 Li 3+ ions, although 7 Li 3+ The charge-to-mass ratio of ions (Z / A=0.43) is further away from the other ions with Z / A ratios close to 0.53.
[0019] The accelerator may have only a single therapeutic ion source, such as α( 4 He 2+ ), 12 C 6+(C6+) or 7 Li 3+ (Li 3+) ion source; or, the accelerator includes at least two therapeutic ion sources, such as α ( 4 He 2+ ) ion source and 7 Li 3+ (Li 3+ ) ion source. In this case, the synchrocyclotron is configured to allow the selection of one or the other therapeutic ion source depending on the desired application.
[0020] When only a single therapeutic ion source α is used, the buncher emits ions at a given frequency F g operation, the frequency F g is equal to the injection frequency of deuterons and alpha ions. When two therapeutic ion sources are used and one or the other is selected, e.g. 7 Li 3+ The ion source and alpha ion source, the buncher is preferably injected at a frequency F that is midway between the treatment ion and imaging ion injection frequencies. g operate.
[0021] In this case, the cyclic frequency law F(t) periodically passes through a frequency greater than F g And the first intermediate value F suitable for injecting and capturing deuterons inj1 , to be less than the first intermediate value and the frequency F g The second intermediate value F inj2 , suitable for injecting and trapping another type of ions, e.g. 7 Li 3+ , the extraction of ions is carried out at a frequency lower than F inj1 and F inj2 Frequency F ex conduct.
[0022] The buncher comprises a central electrode, the length of which is preferably equal to 3βλ / 2 (β=v i / c, where v i is the average velocity of the various ions in the buncher, c is the speed of light, and λ is the frequency F corresponding to the buncher g wavelength).
[0023] The high-frequency modulation means preferably comprises a rotation capacitor and an HF line connecting the accelerating electrode to the rotation capacitor.
[0024] The synchrocyclotron includes a deflector, such as a helical deflector, for deflecting ions from the injection line toward the midplane. For example, the deflector allows the beam to be rotated by 360° to 720° about a vertical axis.
[0025] The synchrocyclotron may comprise an extraction channel, in particular an electromagnetic extraction channel with a membrane, preferably allowing an extraction efficiency greater than 60%.
[0026] Another subject of the invention is a hadron therapy facility comprising a synchrocyclotron according to the invention as described above.
[0027] The facility may include a collimator located downstream of the synchrocyclotron and an imager located downstream of the target volume to receive the deuteron beam. The collimator may be placed upstream of the path modulator.
[0028] Ions from the "treatment" beam allow a therapeutic dose to be deposited in the target volume, while ions from the "imaging" beam are used to produce simultaneous imaging outside the target volume with an imager to obtain spatial information about the "real time" target volume position.
[0029] This improves treatment performance: On the one hand, the ions in the treatment beam are heavier than protons, increasing the lateral and axial ballistic accuracy of dose deposition in the tumor volume where deep delivery is required. On the other hand, the use of ions that are more ionizing than protons increases relative biological efficiency, thereby allowing the destruction of so-called radioresistant tumor cells. Furthermore, the facility offers the possibility of irradiation in very short durations, making so-called "flash therapy" techniques feasible if required.
[0030] The path modulator comprises, for example, a wheel driven in rotation, the wheel comprising blades, the thickness of each blade having an angular variation, in particular a step-wise variation, the rotation of the path modulator being synchronized with the emission of ions accelerated by the synchrocyclotron, so that the ions of the therapeutic beam intended to have a Bragg peak within the target volume pass through the blades with a material thickness allowing obtaining the desired positioning of the Bragg peak, and the ions of the imaging beam intended to reach the imager pass through the path modulator between the blades.
[0031] The device according to the invention offers the possibility of irradiating moving tumors, making it possible to know precisely where the dose is deposited at each moment by means of the imager. The invention allows precise irradiation of "moving targets" with highly ionized ions, such as those caused by breathing in a patient with a lung tumor or swallowing in an ear, nose, and throat tumor, thanks to the real-time knowledge of the dose deposition location provided by the imager. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] The invention may be better understood by reading the following detailed description, non-limiting examples of its implementation, and viewing the accompanying drawings, in which:
[0033] [ Figure 1 ] shows schematically and partly in perspective an example of a synchrocyclotron according to the invention,
[0034] [ Figure 2 ] shows an example of the frequency law F(t) of a synchrocyclotron according to the invention, which accelerates α or 7Li 3+ ions, on the other hand, accelerate deuterons D,
[0035] [ Figure 3 ] shows the phase space for species α, D and Li The delimiter and the corresponding capture area,
[0036] [ Figure 4 ] shows the paths of different ions in water as a function of MeV / nuclear energy,
[0037] [ Figure 5 ] is a schematic and partially exploded view of a portion of a hadron therapy facility located downstream of a synchrocyclotron, with a scanning therapy beam (e.g. consisting of alpha or Li ions) and an imager,
[0038] [ Figure 6 ] illustrates the effect of the buncher on the particle phase along the injection line, and
[0039] [ Figure 7 ] shows three views of an example deflector, namely a view in a vertical plane (left view), a horizontal projection view made in the middle plane of the synchrocyclotron (middle view), and a perspective view (right view). DETAILED DESCRIPTION
[0040] Figure 1 An example of a synchrocyclotron 1 according to the invention is shown. This synchrocyclotron 1 is advantageously part of a hadron therapy facility aimed at delivering a precise dose to a tumour target volume.
[0041] As shown, the synchrocyclotron 1 includes an electromagnet having a generally symmetrical structure with respect to a horizontal median acceleration plane PM and a cutting plane passing through a lower yoke 10 and an upper yoke 11. These yokes 10, 11 and the associated superconducting coils 12 (only the lower coil is shown, without the cryostat containing the coils, their multilayer insulation, and electrical feedthroughs) are generally symmetrical with respect to the median plane PM.
[0042] The synchrocyclotron comprises an HF system comprising a Dee 20 supported by two parallel rods ("stems" in English) 21 and 22. This double-rod structure is described in application FR 3 055 507 A1 in the name of the applicant.
[0043] The synchrocyclotron 1 comprises an HF frequency modulator 23 of the rotating capacitor type, which delivers a frequency law F(t) specific to the characteristics of the accelerated ions and as Figure 2 As shown, this law varies periodically with time.
[0044] Acceleration of the particles occurs in the acceleration gap defined between Dee 20 and anti-Dee 24 (the latter only partially shown).
[0045] The synchrocyclotron 1 comprises an external injection line for the ions to be accelerated, extending along a vertical axis Z.
[0046] The injection line is fed by two devices arranged perpendicular to the vertical axis of the injection line, on either side of the axis, e.g. Figure 1 shown.
[0047] Each of these devices includes:
[0048] a therapeutic ion source 32 , for example of the ECR (Electron Cyclotron Resonance) type, for a therapeutic beam, for example alpha or lithium, located inside a grounded cage 30 and a high-voltage cage 31 ,
[0049] - an imaging ion source (e.g. a multi-tip type within platform 33),
[0050] A chopper 34 or 35 , located downstream of each source, for example consisting of an electrostatic capacitor, which enables the treatment beam or imaging beam to be chopped very quickly and whose operation is controlled by the position of the path modulator, as described below.
[0051] A deflection magnet 36 located on the vertical axis Z allows the beam from the source to be deflected towards the axial injection line.
[0052] The pump 37 ensures a high-quality vacuum.
[0053] In this example, the HF beamformer 38 is at a frequency F g Next work.
[0054] The buncher 38 is, for example, a double-gap type, wherein the length of the central electrode is 3βλ / 2, and the wavelength λ corresponds to the frequency F g .
[0055] In the example considered, the buncher 38 is operated at an injection frequency F of the particles to be accelerated. inj1 and F inj2 The median frequency F g works with its own generator, but still allows achieving satisfactory bunching efficiencies (e.g. up to a factor of 4, i.e. an arbitrary phase separation of 200° at the source exit is reduced to 50° at the injection line end), as Figure 6 shown.
[0056] In the right panel of the figure the final phase and radius of the beam are shown with and without the influence of the buncher, respectively.
[0057] The buncher 38 does not work continuously but in a pulsed mode, i.e. Figure 2 The time period during which the ions to be accelerated are trapped between the "buncher on" and "buncher off" times.
[0058] During the trapping time of the different ion species, packets grouped with a median frequency Fg are injected in time.
[0059] Therefore, if Figure 2 As shown, the buncher 38 is controlled in time, and the duration of operation is controlled by the capture frequency.
[0060] Focusing means 39, for example of the Glaser lens type, allow to ensure the necessary focusing at the input of the injection line deflector 40, which is located at Figure 7 Shown separately in.
[0061] The deflector 40 is, for example, a helical electrostatic type deflector having two oppositely extending nested electrodes 130 and 140, but having the particularity of injecting a relatively high magnetic field (typically between 7 and 8 Tesla) which imposes a rotation greater than 360°, and typically between 360° and 720°, as Figure 7 shown in the middle view. Figure 7 The left view shows the projection in the vertical plane X, Z, the X axis being by convention the axis of the "gap" of the Dee accelerator, the middle view in the horizontal plane, and the right view in perspective.
[0062] The synchrocyclotron includes a beam extraction channel 50, for example of electromagnetic type, in particular with a copper diaphragm. This channel allows relatively high extraction efficiencies (between 60% and 70%) to be achieved. These yields reduce the parasitic neutron flux caused by beam losses in the extraction components. This reduction in neutron flux reduces the general activation of the synchrocyclotron's internal components, which facilitates maintenance operations and reduces the thermal load on the superconducting coils due to the energy deposited by these particle streams. Figure 3 The classical phase space with separators and trapping regions is shown for different types of accelerated ions.
[0063] α and D ions can be captured simultaneously according to the frequency law F(t). Figure 2 As shown, 7 Li 3+ The ions are captured later than the deuterons in the frequency law F(t). The shaded areas are the capture regions, i.e. any initial condition particles outside these regions will not be accelerated by the synchrocyclotron 1. Represents the synchronous phase. When the phase exceeds 90°, the particle is decelerated (the acceleration is agreed to be point represents an unstable fixed point).
[0064] The subsequent injection of α, D ions and 7 Li 3+ The trapping time of ions on the frequency program F(t) is relatively close, for example, according to the frequency law, the trapping time is typically between 10 and 15 μs, such as Figure 2 shown.
[0065] Furthermore, these ions with very close Z / A ratios have different paths in the tissue depending on their kinetic energy expressed in MeV / nucleon (the same kinetic energy expressed in MeV / nucleon means that these ions have the same speed regardless of their mass). In fact, ions with charge Z and mass A have different paths in the material depending on the ratio A / Z. 2 Therefore, if the same A / Z 2 If the ions have the same kinetic energy (usually expressed in MeV per nucleon), their paths are the same.
[0066] Figure 4 The paths in water of various ions that can be accelerated by a synchrocyclotron according to the present invention are shown.
[0067] D: Deuterium, the nucleus of deuterium, a stable heavy isotope of hydrogen.
[0068] α: Helium nucleus ( 4 He 2+ ). α and 1 H 1+ Protons have the same A / Z 2 . Alphas and protons with the same energy in MeV / nucleon have the same path. Although protons cannot be accelerated simultaneously by the synchrocyclotron according to the present invention, Figure 4 Mention them in an indicative manner.
[0069] · 7 Li 3+ Lithium has three electrons stripped from its nucleus. Natural lithium consists of two stable isotopes: lithium with mass A = 6 (7.59% of natural lithium) and lithium with mass A = 7 (92.41% of natural lithium).
[0070] · 12 C 6+ : The nucleus of a carbon atom stripped of 6 electrons can be accelerated with the same frequency law as alpha for shallower radiation.
[0071] Figure 4 By way of example, for a range typically between 180 MeV and 200 MeV per nucleus, deuterons accelerated by a synchrocyclotron according to the invention have a penetration depth of more than 45 cm, allowing them to be used for imaging.
[0072] On the path of the ions that have left the acceleration chamber, upstream of the target volume, the installation comprises a collimator 100 and a path modulator 110, the collimator 100 being placed on the course of the beams to define their cross section, as Figure 5 As shown, and includes an imager 120 downstream of the target volume.
[0073] Depending on the characteristics of the hadron therapy facility, this facility can optionally be completed upstream of the path modulator by conventional optical elements for beam deflection. For example, a facility dedicated to head and neck tumors uses a horizontal fixed beam without the need for an isocentric rotating head.
[0074] The path modulator 110 allows the energy of the extracted beam to be varied in order to better modulate the path of the ions in the target volume.
[0075] The path modulator 110 comprises, for example, a wheel having blades 110a of an absorbent material (eg, polycarbonate) that rotates about an axis parallel to the imaging and treatment beams, such as a Figure 5 Each blade comprises sectors of varying thickness, allowing the depth of the Bragg peak to be modulated.
[0076] In the example shown, the deuteron beam passes through the interstitial region 110 b located between the modulator blades and then through the target volume to the imager 120 .
[0077] The operation of the beam cutter 35 arranged between the source and the beam condenser is controlled by the rotation of the path modulator, for example by an optical signal, to allow the polarized imaging beam to pass through the blades.
[0078] The beam cutoff device 34 is operated in such a way that the ions of the treatment beam always encounter the desired thickness region of the leaf and that no treatment ions are present when no leaf is in the path of the treatment beam. The operation of the beam cutoff devices 34 and 35 takes into account the path time of the ions between the time they pass through the beam cutoff device 34 or 35 and the time they reach the path modulator.
[0079] For example, the imager 120 is constructed with a multiline chamber (a device developed by Georges Charpak consisting of several continuous grids that allows the generation of three-dimensional images of particle trajectories).
[0080] exist Figure 5 In the example of , a synchrocyclotron delivers an alpha treatment beam and a deuteron imaging beam simultaneously, the alpha ion beam resides in the target volume and deposits its Bragg peak there, while the deuteron beam passes through the patient and deposits its Bragg peak in an imager outside the patient.
[0081] Note that the dose integral in the target volume (called SOBP, or spread-out Bragg peak) is affected by the deuteron beam due to the summation of the different variable energy Bragg peaks. However, the contribution to the integrated dose is relatively small because it is upstream of the Bragg peak of the deuteron D, which will be in the imager. This minimum dose deposition can be easily calculated using a dosimetry procedure as part of the preparatory planning for the treatment of the specific volume to be irradiated.
[0082] Of course, the invention is not limited to the examples just given.
[0083] Therefore, you can use Figure 2 Frequency laws other than the frequency law F(t) shown, in particular frequency laws with other frequency values and / or a different shape.
[0084] Other types of ions can be accelerated.
[0085] Other types of deflectors may be used.
[0086] The double rods connecting the HF source to the Dee can be replaced by another connection system.
Claims
1. A superconducting synchrocyclotron accelerator (1), comprising: at least two ion sources for respectively generating a so-called "therapy" beam of at least a first type of ions and a so-called "imaging" beam consisting of deuterons, - an axial injection line comprising at least one high-frequency buncher (38) for bunching ions delivered by the ion source before injecting said ions into the intermediate acceleration plane, - high-frequency modulation means (23) for generating a cyclic frequency law F(t) within the synchrocyclotron, allowing simultaneous acceleration of the ions of the treatment beam and the imaging beam, a rotating path modulator (110), placed in the path of the therapeutic beam and imaged after ion acceleration, comprising at least one solid area (110a) and at least one empty area (110b) positioned alternately during the rotation of the modulator in the path of the beam, the path modulator being capable of modulating the path of the therapeutic ions in the target volume, - two beam cut-off devices (34, 35) upstream of the intermediate acceleration plane for modulating the treatment beam and the imaging beam synchronously with the rotation of the path modulator (110) so that ions of the treatment beam pass only through the at least one solid region (110a) and ions of the imaging beam pass only through the at least one empty region (110b).
2. The superconducting synchrocyclotron (1) according to claim 1, comprising at least two therapeutic ion sources.
3. The synchrocyclotron according to claim 2, comprising an alpha therapeutic ion source and 7 Li 3+ Therapeutic ion sources, the synchrocyclotron being configured to allow selection of one or the other of the therapeutic ion sources depending on the desired application.
4. A synchrocyclotron according to any one of the preceding claims, wherein the buncher (38) is arranged at a frequency F which is midway between the treatment ion injection frequency and the imaging ion injection frequency. g operate.
5. The superconducting synchrocyclotron according to any of the preceding claims, the high-frequency modulation device comprising a rotation capacitor (23) and HF lines (21, 22) connecting an accelerating electrode (20) to the rotation capacitor (23).
6. A superconducting synchrocyclotron according to any of the preceding claims, comprising a deflector, preferably of the spiral type (130, 140), for deflecting ions from the injection line towards a central plane (PM).
7. A hadron therapy facility comprising a synchrocyclotron (1) according to any one of the preceding claims.
8. The facility according to the preceding claim, comprising a collimator (100) located downstream of the synchrocyclotron and an imager (120) for receiving the deuteron beam located downstream of the target volume.
Citation Information
Patent Citations
SUPERCONDUCTOR synchrocyclotron
FR3055507A1
